stents, and the mean CSAs of stents among proximal, mid, and distal segments. But the mean CSA of neointimal hyperplasia at the mid segment was larger

Similar documents
Original Articles Korean Circulation J 1998;28 6 : 항혈소판요법을이용한관동맥내 Stent 삽입술의조기결과 손지원 김영준 손민수 오세진 안태훈 최인석 신익균 Initial Results after Implantation

Original Articles Micro-Ⅱ Stent 의초기결과 류종철 장양수 김건영 이승환 김종현 전동운 심원흠 조승연 Abstract 조홍근 Immediate Results of AVE Micro- Stent Jong Cheol Ryu, M.D

서론 대상및방법 대상환자 관상동맥조영술소견 551

서론 대상및방법 대상환자 스텐트시술방법 관동맥조영술상분석 추적검사및정의 997

Original Articles Korean Circulation J 2000;30 8 : 경요골동맥중재술에서심좌법의유용성에관한연구 최해종 김무현 양창호 차광수 김혜진김성근 이수훈 김상곤 김영대 김종성 Usefulness of Deep Seating Tec

서 론 관찰대상및방법 Fig. 1. Construction of the Crosswire TM distal tip. Table 1. Clinical characteristics and lesion characteristics Characteristics Age year

Microsoft Word - 순2-7.doc

서론 대상 대상및방법 방법 1821

서론 978 Korean Circulation J 1998;286:

황지웅

노영남

- - 대상및방법 대상 방법 Korean Circulation J 2002;328:

ÃÖÇö¿í

Lumbar spine

서론 34 2

Á¦È¯ÁØ

증례 Fig. 1. Computed tomography scan with contrast enhancement demonstrated intramural hematoma extending from aortic arch to thoracic descending aorta

012임수진

A 617

김범수

±èÇ¥³â

134~142특집_최병욱

hwp

1..

원위부요척골관절질환에서의초음파 유도하스테로이드주사치료의효과 - 후향적 1 년경과관찰연구 - 연세대학교대학원 의학과 남상현


Treatment and Role of Hormaonal Replaement Therapy

°ø±â¾Ð±â±â

(Exposure) Exposure (Exposure Assesment) EMF Unknown to mechanism Health Effect (Effect) Unknown to mechanism Behavior pattern (Micro- Environment) Re


Original Articles 관상동맥스텐트시술전에실시한 국소 Nitric Oxide Donor 전달요법효과 Abstract 정명호 * 박종철 차광수 배열 안영근박주형 조정관 * 박종춘 * 강정채 * The Effects of Local Nitric

Original Articles Korean Circulation J 1999;29 9 : Bifurcated Stent-Graft Vanguard 를이용한 복부대동맥류의경관적치료 심원흠 1 최동훈 1 윤영섭 1 이도연 2 장병철 3 Bifurcated S

Microsoft Word doc

Microsoft Word - 순8-8.doc

12이문규

<303820BFF8C0FA D BFC0B0E6BCF62DC1A4B8EDC8A32E687770>


388 The Korean Journal of Hepatology : Vol. 6. No COMMENT 1. (dysplastic nodule) (adenomatous hyperplasia, AH), (macroregenerative nodule, MR

7.ƯÁýb71ÎÀ¯È« š

歯1.PDF

< D B4D9C3CAC1A120BCD2C7C1C6AEC4DCC5C3C6AEB7BBC1EEC0C720B3EBBEC8C0C720BDC3B7C2BAB8C1A4BFA120B4EBC7D120C0AFBFEBBCBA20C6F2B0A E687770>

15(2)-7.fm

(Microsoft PowerPoint - S13-3_\261\350\273\363\307\366 [\310\243\310\257 \270\360\265\345])

저작자표시 - 비영리 - 변경금지 2.0 대한민국 이용자는아래의조건을따르는경우에한하여자유롭게 이저작물을복제, 배포, 전송, 전시, 공연및방송할수있습니다. 다음과같은조건을따라야합니다 : 저작자표시. 귀하는원저작자를표시하여야합니다. 비영리. 귀하는이저작물을영리목적으로이용할

Jksvs019(8-15).hwp

기관고유연구사업결과보고

Microsoft Word - 순8-5.doc

Kbcs002.hwp

자기공명영상장치(MRI) 자장세기에 따른 MRI 품질관리 영상검사의 개별항목점수 실태조사 A B Fig. 1. High-contrast spatial resolution in phantom test. A. Slice 1 with three sets of hole arr

04조남훈

001-학회지소개(영)

433대지05박창용

untitled

<313920C1F5B7CA C1B6C7F6BFC12DC1B6C0B1B0E D E687770>

Exercise - Cantilever Beam

( )Kjhps043.hwp

歯14.양돈규.hwp

< C6AFC1FD28B1C7C7F5C1DF292E687770>

A C O N T E N T S A-132

Trd022.hwp

44-4대지.07이영희532~

Microsoft Word doc

<31372DB9CCB7A1C1F6C7E22E687770>

<3135C1F5B7CA C1B6BCB1BFB52DB0ADC5C2BCF D E687770>

( ) Jkra076.hwp

09구자용(489~500)

139~144 ¿À°ø¾àħ

<30332EC6AFC1FD2DB1E8BCBAC8AF2E687770>

(11+12.).pdf

Pharmacotherapeutics Application of New Pathogenesis on the Drug Treatment of Diabetes Young Seol Kim, M.D. Department of Endocrinology Kyung Hee Univ

untitled

Journal of Educational Innovation Research 2017, Vol. 27, No. 2, pp DOI: : Researc

<35BFCFBCBA2E687770>

637

¾ç½ÂºÎ

03이경미(237~248)ok

Can032.hwp

Contents 이사장 인사말 04 병원장 인사말 05 연혁 06 진료과 소개 08 젊고 건강한 삶을 되찾기 위한 새로운 시작! MH연세병원에서 만날 수 있습니다. 주요센터 소개 14 치과 소개 32 의료장비 소개 34 편의시설 38

Tapered Stent 를사용한경동맥스텐트설치술에대한예비보고 대상과방법 환자군 2008 년 10 월부터 2010 년 8 월까지일률적으로 tapered stent (PROSTE GE TM RX Tapered, ev3 Inc., Plymouth, MN, USA) 를이용하

2.대상 및 범위(계속) 하천 하천 등급 하천명 연장 (km) 연장 (km) 시점 금회수립현황 종점 지방 하천 함안천 경남 함안군 여항면 내곡리 경남 함안군 함안면 함안천(국가)기점 검단천 경남 함안군 칠북면 검단리 칠원천 6.70

전립선암발생률추정과관련요인분석 : The Korean Cancer Prevention Study-II (KCPS-II)

975_983 특집-한규철, 정원호

untitled

( )Jkstro011.hwp

歯49손욱.PDF

歯제7권1호(최종편집).PDF

Microsoft Word - 순3-9.doc

달생산이 초산모 분만시간에 미치는 영향 Ⅰ. 서 론 Ⅱ. 연구대상 및 방법 達 은 23) 의 丹 溪 에 최초로 기 재된 처방으로, 에 복용하면 한 다하여 난산의 예방과 및, 등에 널리 활용되어 왔다. 達 은 이 毒 하고 는 甘 苦 하여 氣, 氣 寬,, 結 의 효능이 있

The Window of Multiple Sclerosis

< FC1F8B9E6B1B3C0B02E687770>

of medication with calcium channel blocker or nitrate compared with those in previous studies. Korean Circulation J 1999;293: KEY WORDSVariant

590호(01-11)

304.fm

16(1)-3(국문)(p.40-45).fm

±è¹ÎÁö


69.fm

Fig. 1. Laryngoscopic findings according to Yonekawa Fig. 2. possible etiologic factors. 2A Smoking, 2B Gastroesophageal reflux symptom, 2C Skin

Ȳ¼º¼ö

ºÎÁ¤¸ÆV10N³»Áö

Transcription:

Original Articles 27 8 1997 혈관내초음파로평가한스텐트를삽입한관동맥의 Abstract 형태학적특징 정남식 홍범기 임세중 백성일 이문형장양수 심원흠 조승연 김성순 Morphological Characteristics of Intimal Hyperplasia in Stented Coronary Arteries Assessed with Intravascular Ultrasound Namsik Chung, M.D., Bum-Kee Hong, M.D., Se-Joong Rim, M.D., Sung-Il Baik, Moon-Hyoung Lee, M.D., Yang-Soo Jang, M.D., Won-Heum Shim, M.D., Seung-Yeon Cho, M.D., Sung-Soon Kim, M.D. Cardiology Division, Yonsei Cardiovascular Center, Yonsei University, Seoul, Korea BackgroundIntravascular ultrasoundivus provides high resolution cross-sectional images of the vessels and permits the quantitative and qualitative assessment of coronary artery disease. Stent is a rigid endovascular lattice that effectively prevents elastic recoil at treated sites, but in-stent restenois is a major limitation. The purpose of the current study is to assess the contribution of neointimal hyperplasia for in-stent restenosis and the distribution and morphological characteristics of neointimal hyperplasia in deployed stents. MethodsThirty patientsmale 25 & female 531 lesions deployed with intracoronary stents underwent intravascular ultrasound imaging at follow-up at least 4 months after stenting[mean SD] 8.32.9 months. Results 1 In-stent restenosis occurred in 15 lesions out of 31 lesions at follow-up coronary angiography. There was no difference in clinical characteristics between the restenotic and the non-restenotic groups. 2 There was no difference in angiographic profiles between two groups. Deployed stents were as follows16 Palmaz-SchatzP-S stents, 12 Gianturco-RoubinG-R stents, 2 Cordis stents, and 1 Microstent II. Average diameter of stents in the restenotic and the non-restenotic groups were 3.07 0.26mm and 3.160.30mm, respectivelyp0.38. 3 There was no difference of stent cross-sectional areascsa between the non-restenotic and the restenotic groupsp0.476, but luminal CSA of the restenotic group was significantly smaller than that of the non-restenotic groupp0.006. 4 In the restenotic group, there were no differences of the maximal and the minimal diameters of 851

stents, and the mean CSAs of stents among proximal, mid, and distal segments. But the mean CSA of neointimal hyperplasia at the mid segment was larger than that at the distal segmentp0.05. There was a tendency that the mean CSA of neointimal hyperplasia at the mid segment was larger than that at the proximal segmentp0.187. These findings were the same in the non-restenotic group. 5 In the restenotic group deployed with P-S stents, there were no differences of the maximal and the minimal diameters of stents, and the mean cross-sectional areascsa of stents between each segment. But, the mean CSA of neointimal hyperplasia at the mid segment was larger than that at the distal segmentp0.05 and there was a tendency that the mean CSA of neointimal hyperplasia at the mid segment was larger than that at the proximal segmentp0.354. 6 In the morphology of neointimal hyperplasia of the restenotic group, eccentric form77%was more common than concentric form22%. Neointimal hyperplasia occurred in focal or diffuse patterns7 versus 8 cases. ConclusionsIn-stent restenosis resulted from neointimal hyperplasia which almost mainly occurred eccentrically at the mid segment of stents and in focal or diffuse patterns. Intravascular ultrasound imaging was a useful method for recognition of distribution and morphological characteristics of neointimal hyperplasia at follow-up of deployed stents. KEY WORDSIntravascular ultrasound Stent restenosis Neointimal hyperplasia. 서론 852

연구대상및방법 1. 대상환자 2. 방법 1) 관동맥조영술 2) 관동맥풍선성형술및스텐트삽입술 3) 관동맥내초음파 853

4) 관동맥내초음파영상의정량분석 Fig. 1. Schematic intravascular ultrasound view of cross sectional structures of stented coronary arteries. The outer thick & inner thin circles represent stent strutsstent cross sectional areacsa and perimeter of neointimal hyperplasia/blood interfacelumen CSA, respectively. The CSA of neointimal hyperplasia is calculated from the difference between stent CSA and lumen CSA. Fig. 2. Morphological characteristics of neointimal hyperplasia classified into concentricc and eccentrice forms. Eccentric forms are further classified into E1, E2, E3, and E4 according to the arc of neointimal hyperplasia in degree as followse1less than 90, E2more than 90 and less than 180, E3more than 180and less than 270, E4more than 270and less than 360. 5) 통계분석 결과 1. 스텐트재협착및비재협착군의임상적특성과관동맥조영소견및스텐트삽입에대한결과분석 854

Table 1. Clinical characteristics in the restenotic versus the non-restenotic group Restenosis Non-restenosis Ageyears 56.09.8 54.69.4 SexMF 141 114 Follow-up durationmonths 8.32.9 8.03.2 Type of ischemic heart diseaselesion AMI with thrombolysis 1 3 AMI without thrombolysis 3 4 Recent MI 2 Angina pectoris, stable 3 2 Angina pectoris, unstable 8 5 AMIAcute myocardial infarction Table 2. Coronary angiographic findings in the restenotic versus the non-restenotic group before stent deployment Restenosis Non-restenosis Extent of coronary artery disease 1 VD 7 7 2 VD 6 72 3 VD 2 Target lesion for stent deployment LAD 11 10 LCX 1 1 RCA 3 5 Lesion characteristics 1 A 1 4 B1 7 5 B2 5 5 C 2 2 VDVessel disease LADLeft anterior descending artery LCX Left ciricumflex artery RCA Right coronary artery 1Classified by ACC/AHA Task Force criteria Table 3. Indications of coronary stenting Restenosis Non-restenosis Bail-out 7 7 Suboptimal result 8 6 Elective 3 Table 4. Types and diameters 1 of deployed stents in the restenotic versus the non-restenotic group Restenosis Non-restenosis Stent type Palmaz-Schatz 10 6 G ianturco-roubin 5 7 Cordis 2 Micro II 1 Stent diameter 1 mm 2.5 1 3.0 11 12 3.5 3 3 4.0 1 Mean 3.070.26 3.160.30 1Diameter at nominal balloon pressure of each stent 855

2. 스텐트가삽입된관동맥의초음파소견 1) 스텐트비재협착군 2) 스텐트재협착군 Table 5. Intravascular ultrasound analysis according to stent segments in the non-restenotic group Stent Diameter of stent 1 Stent Lumen Neointimal segment Maximal Minimal CSA 2 CSA hyperplasia CSA 3 Proximal 3.00.4 2.80.3 6.21.2 5.41.6 0.81.1 Mid 3.00.4 2.90.4 6.62.0 5.31.8* 1.31.6** Distal 3.10.4 2.90.3 6.71.6 6.21.9* 0.50.9** 1Diameter of stentmm2csacross-sectional areamm 2 3Neontimal hyperplasia CSAStent CSA-Lumen CSA *p0.01 &, **p0.05,in-stent mid versus distal segment Table 6. Intravascular ultrasound analysis according to stent segments in the restenotic group Stent Diameter of stent 1 Stent Lumen Neointimal segment Maximal CSA 2 CSA 2 CSA hyperplasia CSA 3 Proximal 3.00.3 2.80.4 6.21.5 4.41.9 1.81.9 Mid 2.90.3 2.80.3 6.31.3 3.21.2* 3.11.5** Distal 2.90.4 2.80.3 6.11.1 5.21.5* 0.91.5** 1Diameter of stentmm2csacross-sectional areamm 2 3Neontimal hyperplasia CSAStent CSA-Lumen CSA *p0.01 &, **p0.05, in-stent mid versus distal segment 856

Table 7. Intravascular ultrasound analysis according to stent segments in the restenotic group deployed with Palmaz-Schatz stent Stent Diameter of stent 1 Stent Lumen Neointimal segment Maximal Minimal CSA 2 CSA hyperplasia CSA 3 Proximal 2.90.3 2.70.2 6.01.1 4.11.7 1.91.8 Mid 2.80.3 2.70.3 6.01.4 3.51.4* 2.61.5** Distal 2.90.3 2.70.3 6.01.3 5.21.4* 0.81.1** 1Diameter of stentmm 2CSACross-sectional areamm 2 3Neontimal hyperplasia CSAStent CSA-Lumen CSA *&, **p0.05, in-stent mid versus distal segment Table 8. Intravascular ultrasound analysis according to stent segments in the restenotic group deployed with Gianturco-Roubin stent Stent Diameter of stent 1 Stent Lumen Neointimal segment Maximal CSA 2 CSA 2 CSA hyperplasia CSA 3 Proximal 3.10.5 3.00.4 6.92.3 5.22.3 1.72.5 Mid 3.10.2 2.90.2 6.71.0 2.60.6 4.21.1* Distal 3.10.5 3.00.2 6.30.8 5.11.7 1.32.5* 1Diameter of stentmm 2CSACross-sectional areamm 2 3Neontimal hyperplasia CSAStent CSA-Lumen CSA *p0.05, in-stent mid versus distal segment Table 9. Morphological characteristics of neointimal hyperplasia according to stent segments in the restenotic group Stent segment C E1 E2 E3 E4 N Proximal 1 3 1 3 7 Mid 5 2 3 4 1 Distal 3 1 11 Cconcentric form of neointimal hyperplasia E eccentric form of neointimal hyperplasica classified by the arc of neointimal hyperplasia in degree as follows E1the arc of neointimal hyperplasia90 E290the arc of neointimal hyperplasia180 E3180the arc of neointimal hyperplasia270 E4270the arc of neointimal hyperplasia 360 NNo neointimal hyperplasia Table 10. Patterns of neointimal hyperplasia in the restenotic group Stent type Pattern 1 Palmaz-Schatz Gianturco-Roubin Total Focal 4 3 7 Diffuse 6 2 8 1 Number of in-stent segments involved with neointimal hyperplasiaonefocal patterntwo diffuse pattern 3) 스텐트내신생내막증식의형태학적특징 857

고안 858

연구의제한점 요약 연구배경 : 방법 : 결과 : 859

결론 : References 1) Vlodaver Z, Frech R, Van Tassel RA, Edwards JE:Correlation of the antemortem coronary arteriogram and the postmortem specimen. Circulation 47:162-169, 1973 2) Eusterman JH, Achor RWP, Kincaid OW, Brown Jr AL: Atherosclerotic disease of the coronary arteries:a pathologic-radiologic correlative study. Circulation 26: 1288-1294, 1982 3) Zir LM, Miller SW, Dinsmore RE, Gilber JP, Harthorne JW:Interobserver variability in coronary angiography. Circulation 53:627-632, 1976 4) Galbraith JE, Murphy ML, Desoyza N:Coronary angiogram interpretation:interobserver variability. JAMA 240:2053-2059, 1981 5) Hemiller JB, Buller CE, Tenaglia AN, Kisslo KB, Phillips HR, Bashore TM, Stack RS, Davidson CJ:Unrecognized left main coronary artery disease in patients undergoing interventional procedures. Am J Cardiol 71:173-176, 1993 6) Tobis JM, Mallery JA, Griffith JM, Mahon D, Bessen M, Voriuchi M, McLeay L, McRae M, Henry WL:Intravascular ultrasound cross sectional arterial imaging before and after balloon angioplasty in vitro. Circulation 80: 873-882, 1989 7) 채장성 : 혈관내초음파영상. 순환기 21:392-400, 1991 8) Gussenhoven EJ, Essed CE:Arterial wall characteristics determined by intravascular imaging:an in vitro study. J Am Coll Cardiol 14:947-955, 1989 9) Yock PG, Fitzgerald PJ, Linker DT, Angelson BAJ:Intravascular ultrasound guidance for catheter-based coronary interventions. J Am Coll Cardiol 17:39B-42B, 1991 10) Mintz GS, Pichard AD, Kovach JA:Impact of preinterventional intravascular ultrasound imaging on transcatheter treatment strategies in coronary artery disease. Am J Coll Cardiol 73:423-430, 1994 11) Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M:A randomized comparison of coronarystent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 331:496-501, 1994 12) Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legarand V, Materne P:A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. BE-NESTENT Study Group. N Engl J Med 331:489-495, 1994 13) Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon M: Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 94:1247-860

1254, 1996 14) Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, Loop FD, Peterson KL, Reeves TJ, Williams SO, Winters WL Jr:A guidelines for percutaneous transluminal coronary angioplasty:a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures(Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 12:529-545, 1988 15) Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L:Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316: 701-706, 1987 16) Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW:Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation 83:148-161, 1991 17) Liu MV, Roubin GS, King SB III:Restenosis after coronary angioplasty:potential biologic determinants and role of intimal hyperplasia. Circulation 79:1374-1387, 1989 18) Bauriedel G, Windstetter U, KeMaio SJ, Kandolf R, Hofling B:Migratory activity of human smooth muscle cells cultivated from coronary and peripheral primary and restenotic lesions removed by percutaneous atherectomy. Circulation 85:554-564, 1992 19) Reidy MA, Fingerle J, Lindner V:Factors controlling the development of arterial lesions after injury. Circulation 96:III-43-III-46, 1992 20) Nissen SE, Gurley JC, Grines CL, Booth DC, McClure R, Berk M, Fischer CH, DeMaria AN:Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 84:1087-1099, 1991 21) Strauss BH, Rensing BJ, Den Boer A, Van der Giessen WJ, Reiber JHC, Serruys PW:Do stents interfere with the densitometric assessment of a coronary artery lesion? Cathet Cardiovasc Diagn 24:259-264, 1991 22) Mudra H, Blasini R, Regar E, Klauss V, Rieber J, Theisen K:Intravascular ultrasound assessment of the balloon-expandable Palmaz-Schatz coronary stent. Coron Artery Dis 4:791-799, 1993 23) Johnson DE, Hinohara T, Selmon MR, Braden LJ, Simpson JB:Primary peripheral arterial stenoses and restenoses excised by transluminal ahterectomy:a histopathologic study. J Am Coll Cardiol 15:419-425, 1990 24) Levine MJ, Leonard BM, Burke JA, Nash ID, Safian RD, Diver DJ:Clinical and angiographic results of balloonexpandable intracoronary stents in right coronary artery stenoses. J Am Coll Cardiol 16:332-339, 1990 25) Kuntz RE, Safian RD, Levine MJ, Reis FJ, Diver DJ, Baim DS:Novel approach to the analysis of restenosis following three new coronary devices. J Am Coll Cardiol 19:1493-1499, 1992 26) Ikari Y, Yamaguchi T, Tamura T, Saeki F, Hara K:Site of restenosis in Palmaz-Schatz coronary stent(abstract). Circulation 88(suppl I):I-641, 1993 27) Dussaillant GR, Mintz GS, Pichard AD, Kent KM, Satler LF, Popma FF, Wong C, Leon MB:Small stent size and intimal hyperplasia contribute to restenosis:a volumetric intravascular ultrasound analysis. J Am Coll Cardiol 26:720-724, 1995 28) Nakamura S, Colombo A, Gaglione A:Intracoronary ultrasound observations during stent implantation. Circulation 89:2026-2034, 1994 29) Yokoi H, Kimura T, Nobuyoshi M:Palmaz-Schatz coronary stent restenosis pattern and management(abstract). J Am Coll Cardiol 23:117A, 1994 30) Fitzgerald PJ, Conolly AJ, Watkins RD:Distinction between soft plaque and thrombus by intravascular ultrasound tissue characterization (Abstract). J Am Coll Cardiol 17:217A, 1991 861